Sublingual Atropine Bioequivalence by Route of Administration (SABER)

NCT06366087 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

FED

Sponsor class

Conditions

Atropine Bioequivalence

Interventions

DRUG: Atropine Sulfate Ophthalmic Solution USP, 1%
DRUG: Atropine Sulfate Injection, USP 8 mg/20 mL (0.4 mg/mL)

Sponsor

Biomedical Advanced Research and Development Authority

Collaborators

[object Object]
[object Object]